Effect of Diuretics Withdrawal in Chronic Heart Failure with Reduced Ejection Fraction
Status:
COMPLETED
Trial end date:
2024-10-31
Target enrollment:
Participant gender:
Summary
REDICAE trial was designed to evaluate the safety and tolerability of diuretics withdrawal in stable, euvolemic chronic outpatients with heart failure with reduced ejection fraction. It is a single-center, randomized, open-label, phase II clinical trial.